Kinase Regulation by Phase Separation

The PhaseKin project aims to uncover the mechanisms of protein kinases in phase-separated condensates to enhance drug development for diseases like Alzheimer's and cancer.

Subsidie
€ 2.499.943
2024

Projectdetails

Introduction

Protein phosphorylation is a process that activates biological and cellular pathways. This process is carried out by enzymes called protein kinases that add phosphates to proteins. Protein kinases are crucial drug targets involved in the onset and progression of human diseases such as cancer and Alzheimer’s disease.

Regulation of Protein Kinases

Growing evidence suggests that protein kinases are regulated spatially and temporally by the phase separation and condensation of biomolecules into cellular organelles that are not surrounded by membranes. The molecular mechanisms that govern the action of kinases in phase-separated condensates, however, are unknown. Knowledge of these mechanisms is crucial for the development of better drugs that target protein kinases.

Project Overview

To address this challenge, I have designed an interdisciplinary project that goes well beyond the state-of-the-art to explore in atomic detail the action of protein kinases intimately involved in Alzheimer’s disease and the abnormal phosphorylation of the protein Tau.

Objectives of the PhaseKin Project

The PhaseKin project aims to:

  1. Reveal the specificity and reaction kinetics of protein kinases inside phase-separated condensates in vitro and in cells.
  2. Decipher the dynamic conformational landscape of the protein kinases MARK2 and GSK3β by advanced NMR methods that will grant unprecedented detail on their modes of regulation.
  3. Disentangle changes in population distributions and rates of interconversion between structurally distinct kinase states inside condensates.
  4. Unravel the physicochemical basis of kinase drug partitioning into condensates.

Innovation and Impact

The highly innovative nature of the project is devised to delve into the heart of protein kinase function and to revolutionize our knowledge about the chemistry of drug-kinase interactions. Findings from the PhaseKin project will provide critical guidance in the development of more efficacious and specific drugs which target protein kinases.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.499.943
Totale projectbegroting€ 2.499.943

Tijdlijn

Startdatum1-9-2024
Einddatum31-8-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EVpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Designer Condensates for Regulation of Catalytic Processes

Develop synthetic biomolecular condensates with tunable properties from peptide libraries to enhance reaction regulation and sustainable drug synthesis in aqueous environments.

€ 1.498.750
ERC Starting...

Deciphering Neurodegenerative Disease with fast 3D imaging & functional nanoscopy

This project aims to investigate the biophysical mechanisms of protein aggregation in Huntington's Disease using advanced imaging techniques to enhance understanding of neurodegenerative processes.

€ 1.500.000
ERC Starting...

Cofactors at the core of tau prion behaviour

This project aims to redefine tau prion strains by investigating how co-aggregation with cofactors influences tau aggregate structure, propagation, and associated neuropathology, enhancing drug discovery for tauopathies.

€ 1.449.750
ERC Starting...

Engineered control of cellular circuits

Developing light-controlled proteins to study spatiotemporal dynamics of signaling in active neuron subpopulations during learning, aiming to inform therapies for brain disorders.

€ 1.494.669
ERC Starting...

Interface between Membraneless Organelles and Membranes

This project aims to uncover the molecular mechanisms of interactions between liquid biomolecular condensates and membrane-bound organelles, enhancing our understanding of cellular organization and disease.

€ 1.499.648